Testing effectiveness (Phase 2)Study completedNCT00589667
What this trial is testing
A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)
Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center 26